Treatment of early-stage HER2+ breast cancer—an evolving field

The evolving field of HER2-targeted therapy has significantly improved the outcome of women diagnosed with HER2-positive invasive breast cancer. In this review, we sought to summarise the efficacy of trastuzumab-based regimens in the adjuvant and neoadjuvant setting with a special emphasis on releva...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Arlindo R, Saini, Kamal S, Metzger-Filho, Otto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406526/
https://www.ncbi.nlm.nih.gov/pubmed/25932047
http://dx.doi.org/10.3332/ecancer.2015.523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406526/
https://www.ncbi.nlm.nih.gov/pubmed/25932047
http://dx.doi.org/10.3332/ecancer.2015.523

Ejemplares similares